retatrutide clinical trial results 2024 Lilly's triple agonist achieves 16.8% weight loss in phase 3 A new clinical trial from

Rather than constantly fighting urges, many report that the urges simply do not arise with their previous intensity or frequency

Elevated heart rate linked to glucagon receptor activation also requires monitoring

Schauer PR, Bhatt DL, Kirwan JP, et al

Managing this alternating pattern requires a balanced approach

Furthermore, additional risk factors identified in some studies include female gender, younger age, lower preoperative body mass index (BMI), and specific types of surgery, such as RYGB and sleeve gastrectomy (SG) [7, 31, 38]

Most notably, the number of included studies providing detailed data on both BC and cardiometabolic parameters was relatively limited